| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |